Patient21 is poised to redefine primary care through enhanced doctor-patient relationships by removing obstacles to seamless healthcare delivery. Founded in 2019 and headquartered in Germany, the company operates within the Health Care and Health and Wellness industries. Patient21's innovative approach focuses on leveraging data to offer personalized treatments, while its network of experts aims to provide a comprehensive view of an individual's health, bringing healthcare into the 21st century.
Recently securing a significant $70.00M Debt Financing investment on 01 May 2023, Patient21 has attracted a consortium of reputable investors including Target Global, PICO Partners, Pitango Venture Capital, Piton Capital, Artian Investments Limited, and Bertelsmann Investments. This funding indicates substantial confidence in the company's vision to build a modern, interconnected healthcare ecosystem.